PAVmed Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
PAVmed Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue3.002.450.380.500.00
Cost of Revenue4.846.423.610.590.00
Gross Profit-1.85-3.97-3.24-0.090.00
Operating Expenses
Research & Development5.9314.2825.3419.8510.96
Selling, General & Administrative36.1548.5360.7334.3212.39
Operating Expenses42.6464.8387.8554.3123.35
Operating Income-44.49-68.80-91.09-54.39-23.35
Other Income/Expense
Interest Income0.250.510.170.000.00
Interest Expense-0.050.59-1.280.00-0.05
Other Income/Expense4.42-10.38-4.331.68-5.99
Income
Income Before Tax28.43-79.26-103.24-56.13-35.89
Income Tax Expense0.00-36.11-24.27-18.940.00
Net Income39.79-64.18-88.98-50.35-34.28
Net Income - Continuous Operations28.43-79.26-103.24-56.130.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-43.29-75.74-88.63-54.17-23.33
EBIT-44.49-78.67-91.09-54.39-23.35
Depreciation & Amortization1.202.022.460.230.02
Earnings Per Share
Basic EPS99.00-275.00-451.00-294.00-328.00
Diluted EPS15.00-275.00-451.00-294.00-328.00
Basic Shares Outstanding0.320.240.200.170.11
Diluted Shares Outstanding2.180.240.200.170.11